ALNY Data

$ALNY | Alnylam Pharmaceuticals, Inc. Social Data » 1) Follower Data, 2) Sentiment Data, 3) Posts Data | Data Mined from SpeculatingStocks Pulse Social Network

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Followers: 1

'Buys': 0 | 'Sells': 0

'Buys' Yesterday: 0 | 'Sells' Yesterday: 0

B/S Rating Today: 0 | B/S Rating All-Time: 0

Avg. Number of Pulses a Day: 0.89 | Total Number of Pulses All-Time: 1090

Total Number of Pulses Yesterday: 1

More: $ALNY (Alnylam Pharmaceuticals, Inc.) Stream, Posts, and Sentiment Page

CLICK for All ALNY POSTS from the ALNY Pulse Symbol Stream

ALNY | Alnylam Pharmaceuticals, Inc. Financial Data » 1) Annual Financials, 2) Quarterly Financials, and 3) Key Metrics

Market Cap: $9.602B

Income Statement:

Revenue: $89.91M

Net Income: $(490.87M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $451.74M

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.69B

Short Term Debt: None

Long Term Debt: $30M

Total Current Assets: $1.76B

Total Current Liabilities: $144.25M

Total Assets: $1.99B

Total Liabilities: $228.3M

Stockholder Equity: $1.77B

Annual ALNY Income Statement

Annual ALNY Cash Flow Statement

Annual ALNY Balance Sheet

Income Statement:

Revenue: $37.92M

Net Income: $(142.23M)

Cash Flow Statement:

Change in Cash / Cash Equiv.: $443.32M

Balance Sheet:

Cash / Cash Equiv. + ST Investments: $1.69B

Short Term Debt: None

Long Term Debt: $30M

Total Current Assets: $1.76B

Total Current Liabilities: $144.25M

Total Assets: $1.99B

Total Liabilities: $228.3M

Stockholder Equity: $1.77B

Quarterly ALNY Income Statement

Quarterly ALNY Cash Flow Statement

Quarterly ALNY Balance Sheet

Market Cap: $9.602B

Trailing PE: N/A

Price to Sales (Based on Most Recent Annual Revenue): 106.8

Price to Book (Based on Most Recent Quarter Stockholder Equity): 5.42

Beta: 3.26

More Key ALNY Financial Metrics

Please Give Tips to Others about Insight Gained from ALNY Financials

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY | Alnylam Pharmaceuticals, Inc. Research » 1) Share Data, 2) Short Data, 3) Insider Data, and 4) Corporate Data

Outstanding Shares: 100.17M

Shares in Float: 47.42M

Percent of Float Short: N/A

Shares Short: N/A

Shares Held by Insiders: 0.44%

Shares Held by Institutions: 98.24%

More ALNY Insider Data

CEO: Mr. Barry E. Greene

Employees: 749

More Corporate Data on ALNY

Please Give Tips to Others about Insight Gained from ALNY Research

Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY | Alnylam Pharmaceuticals, Inc. Charts » 1) 10-Year, 2) 5-Year, 3) 1-Year, 4) 6-Month, 5) 3-Month, 6) 1-Month, 7) 1-Day

↻   Update ALNY Data to Most Recent

↻   Update ALNY Symbol Stream